Cargando…

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease

BACKGROUND: In Wilson’s disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. METHODS: Early neurological d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemssen, Tjalf, Smolinski, Lukasz, Członkowska, Anna, Akgun, Katja, Antos, Agnieszka, Bembenek, Jan, Kurkowska-Jastrzębska, Iwona, Przybyłkowski, Adam, Skowrońska, Marta, Redzia-Ogrodnik, Barbara, Litwin, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469052/
https://www.ncbi.nlm.nih.gov/pubmed/36098934
http://dx.doi.org/10.1007/s13760-022-02091-z
_version_ 1784788552068890624
author Ziemssen, Tjalf
Smolinski, Lukasz
Członkowska, Anna
Akgun, Katja
Antos, Agnieszka
Bembenek, Jan
Kurkowska-Jastrzębska, Iwona
Przybyłkowski, Adam
Skowrońska, Marta
Redzia-Ogrodnik, Barbara
Litwin, Tomasz
author_facet Ziemssen, Tjalf
Smolinski, Lukasz
Członkowska, Anna
Akgun, Katja
Antos, Agnieszka
Bembenek, Jan
Kurkowska-Jastrzębska, Iwona
Przybyłkowski, Adam
Skowrońska, Marta
Redzia-Ogrodnik, Barbara
Litwin, Tomasz
author_sort Ziemssen, Tjalf
collection PubMed
description BACKGROUND: In Wilson’s disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. METHODS: Early neurological deterioration, within 6 months from diagnosis, was defined based on the Unified Wilson’s Disease Rating Scale (UWDRS): any increase in part II or an increase of ≥ 4 in part III. In total, 61 newly diagnosed WD patients were included. UWDRS scores, brain magnetic resonance imaging (MRI) scores, copper metabolism parameters, treatment type and serum neuro-filament light chain (sNfL) concentrations at diagnosis were analysed as potential risk factors of early deterioration. RESULTS: Early neurological deterioration was observed in 16.3% of all WD patients; all cases of worsening occurred in the neurological phenotype (27.7%). Higher scores were seen in those who deteriorated compared with those who did not for UWDRS part II (4.3 ± 5.0 vs 2.0 ± 5.9; p < 0.05), UWDRS part III (21.5 ± 14.1 vs 9.3 ± 16.4; p < 0.01) and MRI-assessed chronic damage (3.2 ± 1.6 vs 1.4 ± 2.2; p = 0.006); all these variables indicated the initial severity of neurological disease. Pre-treatment sNfL concentrations were significantly higher in patients who deteriorated compared with those who did not (33.2 ± 23.5 vs 27.6 ± 62.7 pg/mL; p < 0.01). In univariate logistic regression amongst all patients, chronic damage MRI scores, UWDRS part III scores and sNfL concentrations predicated early deterioration. In the neurological WD, only sNFL were a significant predictor. In bivariate logistic regression amongst all patients, sNfL remained the only significant predictor of deterioration when corrected for MRI scores. CONCLUSION: sNfL concentrations are a promising biomarker of the risk of early neurological deterioration in WD.
format Online
Article
Text
id pubmed-9469052
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-94690522022-09-13 Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease Ziemssen, Tjalf Smolinski, Lukasz Członkowska, Anna Akgun, Katja Antos, Agnieszka Bembenek, Jan Kurkowska-Jastrzębska, Iwona Przybyłkowski, Adam Skowrońska, Marta Redzia-Ogrodnik, Barbara Litwin, Tomasz Acta Neurol Belg Original Article BACKGROUND: In Wilson’s disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. METHODS: Early neurological deterioration, within 6 months from diagnosis, was defined based on the Unified Wilson’s Disease Rating Scale (UWDRS): any increase in part II or an increase of ≥ 4 in part III. In total, 61 newly diagnosed WD patients were included. UWDRS scores, brain magnetic resonance imaging (MRI) scores, copper metabolism parameters, treatment type and serum neuro-filament light chain (sNfL) concentrations at diagnosis were analysed as potential risk factors of early deterioration. RESULTS: Early neurological deterioration was observed in 16.3% of all WD patients; all cases of worsening occurred in the neurological phenotype (27.7%). Higher scores were seen in those who deteriorated compared with those who did not for UWDRS part II (4.3 ± 5.0 vs 2.0 ± 5.9; p < 0.05), UWDRS part III (21.5 ± 14.1 vs 9.3 ± 16.4; p < 0.01) and MRI-assessed chronic damage (3.2 ± 1.6 vs 1.4 ± 2.2; p = 0.006); all these variables indicated the initial severity of neurological disease. Pre-treatment sNfL concentrations were significantly higher in patients who deteriorated compared with those who did not (33.2 ± 23.5 vs 27.6 ± 62.7 pg/mL; p < 0.01). In univariate logistic regression amongst all patients, chronic damage MRI scores, UWDRS part III scores and sNfL concentrations predicated early deterioration. In the neurological WD, only sNFL were a significant predictor. In bivariate logistic regression amongst all patients, sNfL remained the only significant predictor of deterioration when corrected for MRI scores. CONCLUSION: sNfL concentrations are a promising biomarker of the risk of early neurological deterioration in WD. Springer International Publishing 2022-09-13 2023 /pmc/articles/PMC9469052/ /pubmed/36098934 http://dx.doi.org/10.1007/s13760-022-02091-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ziemssen, Tjalf
Smolinski, Lukasz
Członkowska, Anna
Akgun, Katja
Antos, Agnieszka
Bembenek, Jan
Kurkowska-Jastrzębska, Iwona
Przybyłkowski, Adam
Skowrońska, Marta
Redzia-Ogrodnik, Barbara
Litwin, Tomasz
Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
title Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
title_full Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
title_fullStr Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
title_full_unstemmed Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
title_short Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
title_sort serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in wilson’s disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469052/
https://www.ncbi.nlm.nih.gov/pubmed/36098934
http://dx.doi.org/10.1007/s13760-022-02091-z
work_keys_str_mv AT ziemssentjalf serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT smolinskilukasz serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT członkowskaanna serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT akgunkatja serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT antosagnieszka serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT bembenekjan serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT kurkowskajastrzebskaiwona serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT przybyłkowskiadam serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT skowronskamarta serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT redziaogrodnikbarbara serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease
AT litwintomasz serumneurofilamentlightchainandinitialseverityofneurologicaldiseasepredicttheearlyneurologicaldeteriorationinwilsonsdisease